These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
225 related items for PubMed ID: 11593404
1. Early development of polycystic kidney disease in transgenic mice expressing an activated mutant of the beta-catenin gene. Saadi-Kheddouci S, Berrebi D, Romagnolo B, Cluzeaud F, Peuchmaur M, Kahn A, Vandewalle A, Perret C. Oncogene; 2001 Sep 20; 20(42):5972-81. PubMed ID: 11593404 [Abstract] [Full Text] [Related]
2. Hepatomegaly in transgenic mice expressing an oncogenic form of beta-catenin. Cadoret A, Ovejero C, Saadi-Kheddouci S, Souil E, Fabre M, Romagnolo B, Kahn A, Perret C. Cancer Res; 2001 Apr 15; 61(8):3245-9. PubMed ID: 11309273 [Abstract] [Full Text] [Related]
3. Intestinal dysplasia and adenoma in transgenic mice after overexpression of an activated beta-catenin. Romagnolo B, Berrebi D, Saadi-Keddoucci S, Porteu A, Pichard AL, Peuchmaur M, Vandewalle A, Kahn A, Perret C. Cancer Res; 1999 Aug 15; 59(16):3875-9. PubMed ID: 10463573 [Abstract] [Full Text] [Related]
4. Smad1, beta-catenin and Tcf4 associate in a molecular complex with the Myc promoter in dysplastic renal tissue and cooperate to control Myc transcription. Hu MC, Rosenblum ND. Development; 2005 Jan 15; 132(1):215-25. PubMed ID: 15576399 [Abstract] [Full Text] [Related]
5. The human T-cell factor-4 gene splicing isoforms, Wnt signal pathway, and apoptosis in renal cell carcinoma. Shiina H, Igawa M, Breault J, Ribeiro-Filho L, Pookot D, Urakami S, Terashima M, Deguchi M, Yamanaka M, Shirai M, Kaneuchi M, Kane CJ, Dahiya R. Clin Cancer Res; 2003 Jun 15; 9(6):2121-32. PubMed ID: 12796377 [Abstract] [Full Text] [Related]
6. Activation of beta-catenin during hepatocarcinogenesis in transgenic mouse models: relationship to phenotype and tumor grade. Calvisi DF, Factor VM, Loi R, Thorgeirsson SS. Cancer Res; 2001 Mar 01; 61(5):2085-91. PubMed ID: 11280770 [Abstract] [Full Text] [Related]
7. c-myc-induced apoptosis in polycystic kidney disease is independent of FasL/Fas interaction. Couillard M, Guillaume R, Tanji N, D'Agati V, Trudel M. Cancer Res; 2002 Apr 15; 62(8):2210-4. PubMed ID: 11956070 [Abstract] [Full Text] [Related]
8. Activation of different Wnt/beta-catenin signaling components in mammary epithelium induces transdifferentiation and the formation of pilar tumors. Miyoshi K, Rosner A, Nozawa M, Byrd C, Morgan F, Landesman-Bollag E, Xu X, Seldin DC, Schmidt EV, Taketo MM, Robinson GW, Cardiff RD, Hennighausen L. Oncogene; 2002 Aug 15; 21(36):5548-56. PubMed ID: 12165853 [Abstract] [Full Text] [Related]
9. Dysregulation of cellular proliferation and apoptosis mediates human autosomal dominant polycystic kidney disease (ADPKD). Lanoix J, D'Agati V, Szabolcs M, Trudel M. Oncogene; 1996 Sep 19; 13(6):1153-60. PubMed ID: 8808689 [Abstract] [Full Text] [Related]
10. Beta-catenin antisense studies in embryonic liver cultures: role in proliferation, apoptosis, and lineage specification. Monga SP, Monga HK, Tan X, Mulé K, Pediaditakis P, Michalopoulos GK. Gastroenterology; 2003 Jan 19; 124(1):202-16. PubMed ID: 12512043 [Abstract] [Full Text] [Related]
11. Mastermind-like 1 Is a specific coactivator of beta-catenin transcription activation and is essential for colon carcinoma cell survival. Alves-Guerra MC, Ronchini C, Capobianco AJ. Cancer Res; 2007 Sep 15; 67(18):8690-8. PubMed ID: 17875709 [Abstract] [Full Text] [Related]
12. Activation of beta-catenin provides proliferative and invasive advantages in c-myc/TGF-alpha hepatocarcinogenesis promoted by phenobarbital. Calvisi DF, Ladu S, Factor VM, Thorgeirsson SS. Carcinogenesis; 2004 Jun 15; 25(6):901-8. PubMed ID: 14742323 [Abstract] [Full Text] [Related]
13. Aberrant expression and function of TCF4 in the proliferation of hepatocellular carcinoma cell line BEL-7402. Zhao DH, Hong JJ, Guo SY, Yang RL, Yuan J, Wen CY, Zhou KY, Li CJ. Cell Res; 2004 Feb 15; 14(1):74-80. PubMed ID: 15040893 [Abstract] [Full Text] [Related]
14. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis. Hollmann CA, Kittrell FS, Medina D, Butel JS. Oncogene; 2001 Nov 15; 20(52):7645-57. PubMed ID: 11753642 [Abstract] [Full Text] [Related]
15. Phases of canonical Wnt signaling during the development of mouse intestinal epithelium. Kim BM, Mao J, Taketo MM, Shivdasani RA. Gastroenterology; 2007 Aug 15; 133(2):529-38. PubMed ID: 17681174 [Abstract] [Full Text] [Related]
16. Lack of tumorigenesis in the mouse liver after adenovirus-mediated expression of a dominant stable mutant of beta-catenin. Harada N, Miyoshi H, Murai N, Oshima H, Tamai Y, Oshima M, Taketo MM. Cancer Res; 2002 Apr 01; 62(7):1971-7. PubMed ID: 11929813 [Abstract] [Full Text] [Related]
17. APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression. Janssen KP, Alberici P, Fsihi H, Gaspar C, Breukel C, Franken P, Rosty C, Abal M, El Marjou F, Smits R, Louvard D, Fodde R, Robine S. Gastroenterology; 2006 Oct 01; 131(4):1096-109. PubMed ID: 17030180 [Abstract] [Full Text] [Related]
18. Wnt/beta-catenin signaling acts upstream of N-myc, BMP4, and FGF signaling to regulate proximal-distal patterning in the lung. Shu W, Guttentag S, Wang Z, Andl T, Ballard P, Lu MM, Piccolo S, Birchmeier W, Whitsett JA, Millar SE, Morrisey EE. Dev Biol; 2005 Jul 01; 283(1):226-39. PubMed ID: 15907834 [Abstract] [Full Text] [Related]
19. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway. Shan BE, Wang MX, Li RQ. Cancer Invest; 2009 Jul 01; 27(6):604-12. PubMed ID: 19440933 [Abstract] [Full Text] [Related]
20. Conditional mutations of beta-catenin and APC reveal roles for canonical Wnt signaling in lens differentiation. Martinez G, Wijesinghe M, Turner K, Abud HE, Taketo MM, Noda T, Robinson ML, de Iongh RU. Invest Ophthalmol Vis Sci; 2009 Oct 01; 50(10):4794-806. PubMed ID: 19515997 [Abstract] [Full Text] [Related] Page: [Next] [New Search]